Federal award (DEFINITIVE CONTRACT, fiscal year 2024)
Recipient: THE GENEVA FOUNDATION
Awarding agency: Department of Defense / Defense Health Agency
Funding agency: Department of Defense / Department of the Air Force
Period of performance: 2024-09-30 to 2025-09-29
Current total value of award: $561042
Description: RESEARCH AND DEVELOPMENT SERVICES RESEARCH STUDY TITLED, THERAPEUTIC EFFECTS OF THE PTP INHIBITOR (NVG-291) ON SENSORINEURAL HEARING LOSS AFTER PRECISE BLAST-INDUCED AUDITORY INJURY (ST1199 TP INHIBITOR).